Lyell Immunopharma Inc

NASDAQ:LYEL   12:58:39 PM EDT
8.20
+0.27 (+3.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.03B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.7 Million
Adjusted EPS-$0.33
See more estimates
10-Day MA$7.63
50-Day MA$7.14
200-Day MA$6.09
See more pivots

Lyell Immunopharma Inc Stock, NASDAQ:LYEL

201 Haskins Way, Suite 301, South San Francisco, California 94080
United States of America
Phone: +1.650.695.0677
Number of Employees: 190

Description

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.